Neurocrine Biosciences Inc. (NASDAQ: NBIX) completed its acquisition of Soleno Therapeutics Inc., adding VYKAT XR to its rare disease portfolio ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE